Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses - PubMed (original) (raw)
Review
Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses
Shimon Sakaguchi. Annu Rev Immunol. 2004.
Abstract
Naturally occurring CD4+ regulatory T cells, the majority of which express CD25, are engaged in dominant control of self-reactive T cells, contributing to the maintenance of immunologic self-tolerance. Their depletion or functional alteration leads to the development of autoimmune disease in otherwise normal animals. The majority, if not all, of such CD25+CD4+ regulatory T cells are produced by the normal thymus as a functionally distinct and mature subpopulation of T cells. Their repertoire of antigen specificities is as broad as that of naive T cells, and they are capable of recognizing both self and nonself antigens, thus enabling them to control various immune responses. In addition to antigen recognition, signals through various accessory molecules and via cytokines control their activation, expansion, and survival, and tune their suppressive activity. Furthermore, the generation of CD25+CD4+ regulatory T cells in the immune system is at least in part developmentally and genetically controlled. Genetic defects that primarily affect their development or function can indeed be a primary cause of autoimmune and other inflammatory disorders in humans. Based on recent advances in our understanding of the cellular and molecular basis of this T cell-mediated immune regulation, this review discusses how naturally arising CD25+CD4+ regulatory T cells contribute to the maintenance of immunologic self-tolerance and negative control of various immune responses, and how they can be exploited to prevent and treat autoimmune disease, allergy, cancer, and chronic infection, or establish donor-specific transplantation tolerance.
Similar articles
- Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease.
Takahashi T, Sakaguchi S. Takahashi T, et al. Curr Mol Med. 2003 Dec;3(8):693-706. doi: 10.2174/1566524033479429. Curr Mol Med. 2003. PMID: 14682491 Review. - Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A, Caramalho I, Seixas E, Demengeot J. Coutinho A, et al. Curr Top Microbiol Immunol. 2005;293:43-71. doi: 10.1007/3-540-27702-1_3. Curr Top Microbiol Immunol. 2005. PMID: 15981475 Review. - Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E, Sakihama T, Setoguchi R, Tanaka K, Sakaguchi S. Nishimura E, et al. Int Immunol. 2004 Aug;16(8):1189-201. doi: 10.1093/intimm/dxh122. Epub 2004 Jul 5. Int Immunol. 2004. PMID: 15237110 - Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S. Itoh M, et al. J Immunol. 1999 May 1;162(9):5317-26. J Immunol. 1999. PMID: 10228007 - Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.
Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T. Sakaguchi S, et al. Immunol Rev. 2001 Aug;182:18-32. doi: 10.1034/j.1600-065x.2001.1820102.x. Immunol Rev. 2001. PMID: 11722621 Review.
Cited by
- Tumor resident regulatory T cells.
Glasner A, Plitas G. Glasner A, et al. Semin Immunol. 2021 Feb;52:101476. doi: 10.1016/j.smim.2021.101476. Epub 2021 Apr 24. Semin Immunol. 2021. PMID: 33906820 Free PMC article. Review. - Recent successes of cancer immunotherapy: a new dimension in personalized medicine?
Caux C, Zitvogel L. Caux C, et al. Target Oncol. 2012 Mar;7(1):1-2. doi: 10.1007/s11523-012-0211-3. Epub 2012 Feb 15. Target Oncol. 2012. PMID: 22350488 No abstract available. - Regulatory TR3-56 Cells in the Complex Panorama of Immune Activation and Regulation.
Carriero F, Rubino V, Leone S, Montanaro R, Brancaleone V, Ruggiero G, Terrazzano G. Carriero F, et al. Cells. 2023 Dec 15;12(24):2841. doi: 10.3390/cells12242841. Cells. 2023. PMID: 38132162 Free PMC article. Review. - IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB.
Chen CY, Huang D, Yao S, Halliday L, Zeng G, Wang RC, Chen ZW. Chen CY, et al. J Immunol. 2012 May 1;188(9):4278-88. doi: 10.4049/jimmunol.1101291. Epub 2012 Apr 2. J Immunol. 2012. PMID: 22474020 Free PMC article. - n3 PUFAs reduce mouse CD4+ T-cell ex vivo polarization into Th17 cells.
Monk JM, Hou TY, Turk HF, McMurray DN, Chapkin RS. Monk JM, et al. J Nutr. 2013 Sep;143(9):1501-8. doi: 10.3945/jn.113.178178. Epub 2013 Jul 17. J Nutr. 2013. PMID: 23864512 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials